Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 145 Records) |
Query Trace: UGT1A9[original query] |
---|
Effects of ABCB1, UGT1A1, and UGT1A9 Genetic Polymorphisms on the Pharmacokinetics of Sitafloxacin Granules in Healthy Subjects. Clinical pharmacology in drug development 2020 Jul . Sun Lu-Ning, Sun Guo-Xian, Yang Yu-Qing, Shen Ye, Huang Feng-Ru, Xie Li-Jun, Cheng Juan, Zhang Hong-Wen, Zhang Xue-Hui, Liu Yun, Wang Yong-Qi |
Human variability in isoform-specific UDP-glucuronosyltransferases: markers of acute and chronic exposure, polymorphisms and uncertainty factors. Archives of toxicology 2020 5 94 (8): 2637-2661. Kasteel E E J, Darney K, Kramer N I, Dorne J L C M, Lautz L |
Population pharmacokinetics of mycophenolic acid in adult kidney transplant patients under prednisone and tacrolimus regimen. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2020 5 150 105370. Reséndiz-Galván Juan Eduardo, Romano-Aguilar Melissa, Medellín-Garibay Susanna Edith, Milán-Segovia Rosa Del Carmen, Niño-Moreno Perla Del Carmen, Jung-Cook Helgi, Chevaile-Ramos José Alejandro, Romano-Moreno Silv |
Lack of Relationship Between Renal Function and Genetic Variants of CYP3A4, CYP3A5, MDR1, MRP2, UGT1A9, UGT1A8, and UGT2B7 in Patients After Liver Transplantation in a 2-Year Follow-up. Transplantation proceedings 2020 Apr . Hryniewiecka Ewa, Zegarska Jolanta, Zochowska Dorota, P?czek Lesz |
Worsening of Kidney Transplant Function During 2-Year Follow-up Is Associated With the Genetic Variants of CYP3A4, MDR1, and UGT1A9. Transplantation proceedings 2020 Mar . Hryniewiecka Ewa, Zegarska Jolanta, Zochowska Dorota, P?czek Lesz |
Effect of UGT polymorphisms on pharmacokinetics and adverse reactions of mycophenolic acid in kidney transplant patients. Pharmacogenomics 2021 9 22 (15): 1019-1040. Jiang Zhenwei, Hu N |
Genetic polymorphisms in metabolic enzymes and transporters have no impact on mycophenolic acid pharmacokinetics in adult kidney transplant patients co-treated with tacrolimus: A population analysis. Journal of clinical pharmacy and therapeutics 2021 7 46 (6): 1564-1575. Yang Chun-Lan, Sheng Chang-Cheng, Liao Gui-Yi, Su Yong, Feng Li-Juan, Xia Quan, Jiao Zheng, Xu Du-Ju |
The Impact of Genetic Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Mycophenolic Acid: Systematic Review and Meta-analysis. Clinical pharmacokinetics 2021 Jun . Na Takuathung Mingkwan, Sakuludomkan Wannachai, Koonrungsesomboon N |
Influence of SLCO1B1 521T>C, UGT2B7 802C>T and IMPDH1 -106G>A Genetic Polymorphisms on Mycophenolic Acid Levels and Adverse Reactions in Chinese Autoimmune Disease Patients. Pharmacogenomics and personalized medicine 2021 6 14 713-722. Shu Qing, Fan Qingqing, Hua Bingzhu, Liu Hang, Wang Shiying, Liu Yunxing, Yao Yao, Xie Han, Ge Weiho |
CYP3A5 and UGT1A9 Polymorphisms Influence Immunosuppressive Therapy in Pediatric Kidney Transplant Recipients. Frontiers in pharmacology 2021 5 12 653525. Krall Paola, Yañez Dominique, Rojo Angélica, Delucchi Ángela, Córdova Miguel, Morales Jorge, Boza Pía, de la Rivera Alonso, Espinoza Natalie, Armijo Natalia, Castañeda Luis E, Farfán Mauricio J, Salas Caroli |
Meta-Analysis of Noncompartmental Pharmacokinetic Parameters of Ertugliflozin to Evaluate Dose Proportionality and UGT1A9 Polymorphism Effect on Exposure. Journal of clinical pharmacology 2021 Apr . Marshall Jean-Claude, Liang Yali, Sahasrabudhe Vaishali, Tensfeldt Thomas, Fediuk Daryl J, Zhou Susan, Krishna Rajesh, Dawra Vikas Kumar, Wood Linda S, Sweeney Kev |
Associations among plasma concentrations of regorafenib and its metabolites, adverse events, and ABCG2 polymorphisms in patients with metastatic colorectal cancers. Cancer chemotherapy and pharmacology 2021 2 87 (6): 767-777. Kobayashi Kazuo, Sugiyama Erika, Shinozaki Eiji, Wakatsuki Takeru, Tajima Masataka, Kidokoro Hiyori, Aoyama Takeshi, Nakano Yasuhiro, Kawakami Kazuyoshi, Hashimoto Koki, Suenaga Mitsukuni, Ichimura Takashi, Ogura Mariko, Chin Keisho, Nakayama Izuma, Ooki Akira, Takahari Daisuke, Suzuki Wataru, Yokokawa Takashi, Minowa Yuichi, Hiraoka Tomoko, Suzuki Kenichi, Sato Hitoshi, Hama Toshihiro, Yamaguchi Kens |
Common UGT1A9 polymorphisms do not have a clinically meaningful impact on the apparent oral clearance of dapagliflozin in type 2 diabetes mellitus. British journal of clinical pharmacology 2021 Oct . Naagaard M Daniel, Chang Roy, Någård Mats, Tang Weifeng, Boulton David |
Impact of Pharmacogenetic Determinants of Tacrolimus and Mycophenolate on Adverse Events in Renal Transplant Patients. Current drug metabolism 2021 Jan . Thishya Kalluri, Sreenu Boddupally, Raju Shree Bhushan, Kutala Vij |
Use of Pharmacogenetics to Optimize Immunosuppressant Therapy in Kidney-Transplanted Patients. Biomedicines 2022 7 10 (8): . Urzì Brancati Valentina, Scarpignato Carmelo, Minutoli Letteria, Pallio Giovan |
The pharmacogenetics of mycophenolate mofetil in Tunisian renal transplant patients. Personalized medicine 2022 6 19 (5): 383-393. Abderahmene Amani, Ellouz Amel, Amor Dorra, Ajmi Marwa, Khalij Yassine, Hamdouni Haithem, Sahtout Wissal, Azzabi Awatef, Omezzine Asma, Achour Abdellatif, Bouslama A |
SLC4A4, FRAS1, and SULT1A1 Genetic Variations Associated With Dabigatran Metabolism in a Healthy Chinese Population. Frontiers in genetics 2022 6 13 873031. Xie Qiufen, Li Yuan, Liu Zhiyan, Mu Guangyan, Zhang Hanxu, Zhou Shuang, Wang Zhe, Wang Zining, Jiang Jie, Li Xin, Xiang Qian, Cui Yim |
Meta-analysis of the associations of IMPDH and UGT1A9 polymorphisms with rejection in kidney transplant recipients taking mycophenolic acid. European journal of clinical pharmacology 2022 May . Cheng Lin, Yao Pu, Weng Bangbi, Yang Ming, Wang Qi |
Common UGT1A6 Variant Alleles Determine Acetaminophen Pharmacokinetics in Man. Journal of personalized medicine 2022 5 12 (5): . Cerezo-Arias María de Las Olas, Gómez-Tabales Javier, Martí Manuel, García-Martín Elena, Agúndez José A |
Pharmacogene Variants Associated with Liver Transplant in a Twelve-Year Clinical Follow-Up. Pharmaceutics 2022 Feb 14 (2): . Sendra Luis, Olivera Gladys G, López-Andújar Rafael, Serrano Cristina, Rojas Luis E, Montalvá Eva María, Herrero María José, Aliño Salvador |
GABRA1 and GABRB2 Polymorphisms are Associated with Propofol Susceptibility. Pharmacogenomics and personalized medicine 2022 15 105-117. Zeng Youjie, Cao Si, Chen Minghua, Fang Chao, Ouyang W |
Effect of null (c.516G>T), null (c.1075A>C) and null (c.98T>C) polymorphisms on propofol pharmacokinetics in patients submitted to colonoscopy: a cohort study. Postgraduate medical journal 2022 2 . Poma Mara Aparecida Maricato, Ribeiro Junior Howard Lopes, Costa Eugênio Araújo, Paier Carlos Roberto Koscky, Brasil Laís Lacerda, Lima Luína Benevides, Nobre Livia Maria Soares, Leite Tayales Tavares, Lima-Júnior Roberto César Pereira, Quidute Ana Rosa Pinto, de Moraes Maria Elisabete Amaral, Moraes Filho Manoel Odorico |
Significance of UGT1A6, UGT1A9, and UGT2B7 genetic variants and their mRNA expression in the clinical outcome of renal cell carcinoma. Molecular and cellular biochemistry 2022 12 . Matsumoto Jun, Nishimoto Anzu, Watari Shogo, Ueki Hideo, Shiromizu Shoya, Iwata Naohiro, Takeda Tatsuaki, Ushio Soichiro, Kajizono Makoto, Fujiyoshi Masachika, Koyama Toshihiro, Araki Motoo, Wada Koichiro, Zamami Yoshito, Nasu Yasutomo, Ariyoshi Norita |
Population pharmacokinetics of mycophenolate mofetil in pediatric patients early after liver transplantation. Frontiers in pharmacology 2022 10 13 1002628. Wei Yinyi, Wu Dongni, Chen Yiyu, Dong Chunqiang, Qi Jianying, Wu Yun, Cai Rongda, Zhou Siru, Li Chengxin, Niu Lulu, Wu Tingqing, Xiao Yang, Liu Taot |
Polymorphisms of pharmacogenetic candidate genes affect etomidate anesthesia susceptibility. Frontiers in genetics 2022 10 13 999132. Ma Lulin, Huang Yan, Huang Shiqian, Xu Feng, Wang Yafeng, Zhao Shuai, Deng Daling, Ding Yuanyuan, Zhang Tianhao, Zhao Wenjing, Chen Xiangdo |
Effects of Genetic Variants in the Nicotine Metabolism Pathway on Smoking Cessation. Genetics research 2022 2022 2917881. Li Huijie, Wang Qiang, Li Suyun, Jia Chong |
The UGT1A9*22 genotype identifies a high-risk group for irinotecan toxicity among gastric cancer patients. Genomics & informatics 2022 Sep 20 (3): e29. Lee Choong-Kun, Chon Hong Jae, Kwon Woo Sun, Ban Hyo-Jeong, Kim Sang Cheol, Kim Hyunwook, Jeung Hei-Cheul, Chung Jimyung, Rha Sun You |
A single nucleotide polymorphism-based formula to predict the risk of propofol TCI concentration being over 4?µg?mL at the time of loss of consciousness. The pharmacogenomics journal 2022 1 22 (2): 109-116. Zheng Zhuoling, Xue Faling, Wang Haini, He Yongqi, Zhang Lingyi, Ma Wudi, Zhang Caibin, Guan Yanping, Ye Fang, Wen Yongzi, Li Xiaoyan, Huang Min, Huang Wenqi, Wang Zhongxing, Li Jia |
Effect of CYB2B6 (c.516G>T), CYP2C9 (c.1075A>C) and UGT1A9 (c.98T>C) polymorphisms on propofol pharmacokinetics in patients submitted to colonoscopy: a cohort study. Postgraduate medical journal 2023 5 99 (1170): 286-295. Mara Aparecida Maricato Poma, Howard Lopes Ribeiro Junior, Eugênio Araújo Costa, Carlos Roberto Koscky Paier, Laís Lacerda Brasil, Luína Benevides Lima, Livia Maria Soares Nobre, Tayales Tavares Leite, Roberto César Pereira Lima-Júnior, Ana Rosa Pinto Quidute, Maria Elisabete Amaral de Moraes, Manoel Odorico de Moraes Fil |
Role of SLC5A2 polymorphisms and effects of genetic polymorphism on sodium glucose cotransporter 2 inhibitorsinhibitor response. Molecular biology reports 2023 10 . Bo Xu, Shaoqian Li, Bo Kang, Shangzhi Fan, Canyu Chen, Weiyi Li, Jixiang Chen, Zunbo He, Fan Tang, Jiecan Zh |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: